Article révisé par les pairs
Titre:
  • Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Auteur:Spicka, Ivan; Ocio, Enrique María; Oakervee, Heather H.E.; Greil, Richard; Banh, Raymond H; Huang, Shang Yi; D'Rozario, James M; Dimopoulos, Meletios Athanassios; Martínez, Sara; Extremera, Sonia; Kahatt, Carmen; Alfaro, Vicente; Carella, Angelo Michele; Meuleman, Nathalie; Hájek, Roman; Symeonidis, Argiris; Min, Chang Ki; Cannell, Paul; Ludwig, Heinz; Sonneveld, Pieter; Mateos, Maria-Victoria
Informations sur la publication:Annals of hematology, 98, 9, page (2139-2150)
Statut de publication:Publié, 2019-09-01
Sujet CREF:Sciences bio-médicales et agricoles
Hématologie
Mots-clés:Dexamethasone
Multiple myeloma
Plitidepsin
Refractory
Relapsed
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Bortezomib -- administration & dosage
Depsipeptides -- administration & dosage
Dexamethasone -- administration & dosage
Disease-Free Survival
Female
Humans
Lenalidomide -- administration & dosage
Male
Middle Aged
Multiple Myeloma -- drug therapy -- mortality
Survival Rate
Thalidomide -- administration & dosage
Langue:Anglais
Identificateurs:urn:issn:0939-5555
info:doi/10.1007/s00277-019-03739-2
info:pii/10.1007/s00277-019-03739-2
info:scp/85067997315
info:pmid/31240472
PMC6700046

Documents en relation

DI-fusion